Selinexor and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Aggressive Non-Hodgkin Lymphoma
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
University of Pennsylvania
University of Wisconsin, Madison
Swiss Cancer Institute
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
Ohio State University Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Alliance for Clinical Trials in Oncology
Ohio State University Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Indiana University
Ohio State University Comprehensive Cancer Center
Rutgers, The State University of New Jersey
Memorial Sloan Kettering Cancer Center
Northwestern University
NYU Langone Health
Roswell Park Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Arizona
Virginia Commonwealth University
Rutgers, The State University of New Jersey